[Federal Register: January 22, 2008 (Volume 73, Number 14)]
[Notices]
[Page 3713]
[DOCID:fr22ja08-51]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket Nos. CP06-61-004 and CP01-23-005]

 North Baja Pipeline, LLC; Notice of Compliance Filing

January 15, 2008.
    Take notice that on January 11, 2008, North Baja Pipeline, LLC
(NBP) tendered for filing as part of its FERC Gas Tariff, certain
revised tariff sheets, with an effective date of February 15, 2008.
    NBP states that the filing is being made in compliance with the
Commission's order issued on October 2, 2007 in the above-referenced
proceeding.
    Any person desiring to protest this filing must file in accordance
with Rule 211 of the Commission's Rules of Practice and Procedure (18
CFR 385.211). Protests to this filing will be considered by the
Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Such protests
must be filed on or before the date as indicated below. Anyone filing a
protest must serve a copy of that document on all the parties to the
proceeding.
    The Commission encourages electronic submission of protests in lieu
of paper using the ``eFiling'' link at http://www.ferc.gov. Persons

unable to file electronically should submit an original and 14 copies
of the protest to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time January 22, 2008.

 Kimberly D. Bose,
Secretary.
 [FR Doc. E8-966 Filed 1-18-08; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 150 (Thursday, August 4, 2016)]
[Notices]
[Pages 51538-51540]
[FR Doc No: 2016-18499]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2015-0323]

Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA).

ACTION: Notice of applications for exemptions; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 21 individuals
for an exemption from the prohibition against persons with a clinical
diagnosis of epilepsy or any other condition that is likely to cause a
loss of consciousness or any loss of ability to operate a commercial
motor vehicle (CMV) in interstate commerce. If granted, the exemptions
would enable these individuals who have had one or more seizures and
are taking anti-seizure medication to operate CMVs for up to 2 years in
interstate commerce.

DATES: Comments must be received on or before September 6, 2016.

ADDRESSES: You may submit comments to the Federal Docket Management
System (FDMS) Docket No. FMCSA-2015-0323 using any of the following
methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
docket numbers for this notice. Note that all comments received will be
posted without change to http://www.regulations.gov, including any
personal information provided. Please see the Privacy Act heading below
for further information.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The Federal Docket Management System (FDMS) is
available 24 hours each day, 365 days each year. If you want
acknowledgment that we received your comments, please include a self-
addressed, stamped envelope or postcard or print the acknowledgement
page that appears after submitting comments on-line.
    Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to http://www.regulations.gov as described in
the system records notice (DOT/ALL-14 FDMS), which can be reviewed at
http://www.dot.gov/privacy.

FOR FURTHER INFORMATION CONTACT: Christine A. Hydock, Chief, Medical
Programs Division,<PHONE_NUMBER>, or via email at
<EMAIL_ADDRESS>or by letter to FMCSA, Room W64-113, Department
of Transportation, 1200 New Jersey Avenue SE., Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday,
except Federal holidays.

SUPPLEMENTARY INFORMATION:

I. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
for up to a 2-year period if it finds ``such exemption would likely
achieve a level of safety that is equivalent to or greater than the
level that would be achieved absent such exemption.'' The statutes
allow the Agency to renew exemptions at the end of the 2-year period.
The 21 individuals listed in this notice have requested an exemption
from the epilepsy prohibition in 49 CFR 391.41(b)(8), which applies to
drivers who operate CMVs in interstate commerce. Accordingly, the
Agency will evaluate the qualifications of each applicant to determine
whether granting the exemption will achieve the required level of
safety mandated by statute.
    The physical qualification standard for drivers regarding epilepsy
found in 49 CFR 391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person:

    Has no established medical history or clinical diagnosis of
epilepsy or any other condition which is likely to cause the loss of
consciousness or any loss of ability to control a CMV.

    In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners in determining whether drivers
with certain medical conditions are qualified to operate a CMV in
interstate commerce. [49 CFR part 391, APPENDIX A TO PART 391--MEDICAL
ADVISORY CRITERIA, section H. Epilepsy: Sec.  391.41(b)(8), paragraphs
3, 4, and 5.]
---------------------------------------------------------------------------

    \1\ See http://www.ecfr.gov/cgi-bin/text-idx?SID=e47b48a9ea42dd67d999246e23d97970&mc=true&node=pt49.5.391&rgn=div5#ap49.5.391_171.a and https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

    The advisory criteria states that if an individual has had a sudden
episode of a non-epileptic seizure or loss of consciousness of unknown
cause that did not require anti-seizure medication, the decision
whether that person's condition is likely to cause the loss of
consciousness or loss of ability to control a CMV should be made on an
individual basis by the medical examiner in consultation with the
treating physician. Before certification is considered, it is suggested
that a 6-month waiting period elapse from the time of the episode.
Following the waiting period, it is suggested that the individual have
a complete neurological examination. If the results of the examination
are negative and anti-seizure medication is not required, then the
driver may be qualified.
    In those individual cases where a driver had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has recovered fully from that
condition, has no existing residual complications, and is not taking
anti-seizure medication.
    Drivers who have a history of epilepsy/seizures, off anti-seizure

medication and seizure-free for 10 years, may be qualified to operate a
CMV in interstate commerce. Interstate drivers with a history of a
single unprovoked seizure may be qualified to drive a CMV in interstate
commerce if seizure-free and off anti-seizure medication for a 5-year
period or more.
    As a result of medical examiners misinterpreting advisory criteria
as regulation, numerous drivers have been prohibited from operating a
CMV in interstate commerce based on the fact that they have had one or
more seizures and are taking anti-seizure medication, rather than an
individual analysis of their circumstances by a qualified medical
examiner based on the physical qualification standards and medical best
practices.

II. Qualifications of Applicants

Jason J. Amoriello

    Mr. Amoriello is a 42 year-old driver in Wisconsin. He has a
history of a seizure disorder and has remained seizure free since 1984.
He takes anti-seizure medication with the dosage and frequency
remaining the same since 2012. His physician states that he is
supportive of Mr. Amoriello receiving an exemption.

Mark Douglas Anderson

    Mr. Anderson is a 52 year-old class B CDL holder in North Carolina.
He has a history of a seizure disorder and has remained seizure free
since 1991. He takes anti-seizure medication with the dosage and
frequency remaining the same since that time. His physician states that
he is supportive of Mr. Anderson receiving an exemption.

Jeffrey Neal Bienstock

    Mr. Bienstock is a 48 year-old class A CDL holder in Arizona. He
has a history of a seizure disorder and has remained seizure-free since
2003. He discontinued anti-seizure medication in 2008. His physician
states that he is supportive of Mr. Bienstock receiving an exemption.

Jeremy Neal Bradford

    Mr. Bradbord is a 39 year-old class A CDL holder in Alabama. He has
a history of epilepsy and has remained seizure-free since 2004. He
takes anti-seizure medication with the dosage and frequency remaining
the same since 2013. His physician states that he is supportive of Mr.
Bradford receiving an exemption.

Joseph Steven Drion

    Mr. Drion is a 52 year-old class B CDL holder in Missouri. He has a
history of a seizure disorder and has remained seizure-free since 2002.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Drion receiving an exemption.

Kenneth B. Elder

    Mr. Elder is a 49 year-old class A CDL holder in Kentucky. He has a
history of a seizure disorder and has remained seizure-free since 2002.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Elder receiving an exemption.

Steven W. Farver

    Mr. Farver is a 50 year-old driver in Pennsylvania. He has a
history of a seizure disorder and has remained seizure-free since 2008.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Farver receiving an exemption.

Richard M. Foster

    Mr. Foster is a 49 year-old driver in Oklahoma. He has a history of
a seizure disorder and has remained seizure-free since 2007. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. His physician states that he is supportive of Mr.
Foster receiving an exemption.

Jeffrey Brett Green

    Mr. Green is a 42 year-old class B CDL holder in California. He has
a history of a seizure disorder and has remained seizure-free since
2008. He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Green receiving an exemption.

Stephen M. Harmon

    Mr. Harmon is a 39 year-old driver in West Virginia. He has a
history of a seizure disorder and has remained seizure-free since
January 2005. He takes anti-seizure medication with the dosage and
frequency remaining the same since 2010. His physician states that he
is supportive of Mr. Harmon receiving an exemption.

Donald Horst

    Mr. Horst is a 66 year-old driver in Maryland. He has a history of
a single seizure in 2009. He takes anti-seizure medication with the
dosage and frequency remaining the same since that time. His physician
states that he is supportive of Mr. Horst receiving an exemption.

Jordan M. Hyster

    Mr. Hyster is a 27 year-old class A CDL holder in Ohio. He has a
history of a seizure disorder and has remained seizure-free since
January 2009. He takes anti-seizure medication with the dosage and
frequency remaining the same since that time. His physician states that
he is supportive of Mr. Hyster receiving an exemption.

Christopher A. Koger

    Mr. Koger is a 42 year-old class A CDL holder in Pennsylvania. He
has a history of a seizure disorder and has remained seizure-free since
2007. He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Koger receiving an exemption.

Kyle Philip Loney

    Mr. Loney is a 32 year-old driver in Washington. He has a history
of a seizure disorder and has remained seizure-free since January 2004.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Loney receiving an exemption.

Leigh P. Mallory

    Mr. Mallory is a 65 year-old driver in Vermont. He has a history of
a seizure disorder and has remained seizure-free since 1997. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. His physician states that he is supportive of Mr.
Mallory receiving an exemption.

Sean Nesbitt

    Mr. Nesbitt is a 44 year-old driver in New York. He has a history
of a seizure disorder and has remained seizure-free since 2009. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Nesbitt receiving an exemption.

Ashley Nicole Rialson

    Ms. Rialson is a 28 year-old driver in Minnesota. She has a history
of epilepsy and has remained seizure-free since 2005. She takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. Her physician states that she is supportive of Ms.
Rialson receiving an exemption.

Gonzalin Sanabria

    Mr. Sanabria is a 61 year-old class B CDL holder in New York. He
has a history of a seizure disorder as the result of brain lymphoma
that was diagnosed in 2003. He remains in remission and has been
seizure free since 2004. He takes anti-seizure medication with the
dosage and frequency remaining the same since that time. His physician
states that he is supportive of Mr. Sanabria receiving an exemption.

David Sica

    Mr. Sica is a 53 year-old driver in Connecticut. He has a history
of a seizure disorder and has remained seizure free since 1985. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Sica receiving an exemption.

Raymond H. Van De Mark

    Mr. Van De Mark is a 62 class A CDL holder in New Jersey. He has a
history of a seizure disorder and has remained seizure free since 1986.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Van De Mark receiving an exemption.

William Frederick Youse

    Mr. Youse is a 24 year-old driver in North Carolina. He has a
history of childhood epilepsy and has been seizure free since 2002. He
has not taken anti-seizure medication since 2005. His physician states
that he is supportive of Mr. Youse receiving an exemption.

III. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the notice.

IV. Submitting Comments

    You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission.
    To submit your comment online, go to http://www.regulations.gov and
in the search box insert the docket number ``FMCSA-2015-0323'' and
click the search button. When the new screen appears, click on the blue
``Comment Now!'' button on the right hand side of the page. On the new
page, enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope.
    We will consider all comments and materials received during the
comment period. FMCSA may issue a final determination any time after
the close of the comment period.

V. Viewing Comments and Documents

    To view comments, as well as any documents mentioned in this
preamble, go to http://www.regulations.gov and in the search box insert
the docket number FMCSA-2015-0323 and click ``Search.'' Next, click
``Open Docket Folder'' and you will find all documents and comments
related to this notice.

    Issued on: July 27, 2016.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2016-18499 Filed 8-3-16; 8:45 am]
 BILLING CODE 4910-EX-P


[Federal Register Volume 85, Number 18 (Tuesday, January 28, 2020)]
[Notices]
[Pages 4969-4970]
[FR Doc No: 2020-01443]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL20-19-000]

Notice of Complaint: Coalition of MISO Transmission Customers,
Industrial Energy Consumers of America, LS Power Midcontinent, LLC v.
Midcontinent Independent System Operator, Inc.

    Take notice that on January 21, 2020, pursuant to sections 206, 306
and 309 of the Federal Power Act, 16 U.S.C. 824e, 825e and 825h and
Rule 206 of the Federal Energy Regulatory Commission's (Commission)
Rules of Practice and Procedure, 18 CFR 385.206 (2019), Coalition of
MISO Transmission Customers, Industrial Energy Consumers of America and
LS Power Midcontinent, LLC (collectively, Complainants) filed a formal
complaint against Midcontinent Independent System Operator, Inc. (MISO
or Respondent) requesting that the Commission direct MISO to revise the
cost allocation methodology for Baseline Reliability Projects, all as
more fully explained in the complaint.
    Complainant certifies that copies of the Complaint were served on
the contacts for MISO as listed on the Commission's list of Corporate
Officials.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of

intervention or motion to intervene, as appropriate. The Respondent's
answer and all interventions, or protests must be filed on or before
the comment date. The Respondent's answer, motions to intervene, and
protests must be served on the Complainants.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov. Persons unable to file electronically should submit an
original and 5 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street NE, Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
``eSubscription'' link on the website that enables subscribers to
receive email notification when a document is added to a subscribed
docket(s). For assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5:00 Eastern Time on February 10, 2020.

    Dated: January 22, 2020.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2020-01443 Filed 1-27-20; 8:45 am]
 BILLING CODE 6717-01-P